science behind tirzepatide Is Safe For Long-Term Use? A 2026 Clinical Perspective Tirzepatide 5mg | FDA-Approved Diabetes

17% Acid reflux: 28% vs

Operational and Technical Challenges: Recruitment: Enrollment of a specific patient population, particularly one that is heterogeneous (obese individuals and T2DM patients), may pose recruitment challenges

doi: 10.1152/ajpendo.00161.2015

Comprehensive medical assessment is essential before initiating weight loss injection therapy, particularly for patients with known or suspected fatty liver disease

Additionally, patients should report persistent nausea, vomiting, or diarrhoea , as these may lead to dehydration and exacerbate hypotension

Although hypoglycemia is uncommon when these medications are used on their own, it becomes a concern for patients taking other diabetes treatments simultaneously